Seer appoints Anthony Bazarko as Chief Commercial Officer

Seer, Inc.

Anthony Bazarko named CCO effective May 4, 2026; previously President & CEO of Biologos and CCO at Specific Diagnostics.
Bazarko brings over 20 years of commercial leadership in life sciences, diagnostics, and biotech.
He will lead Seer's Sales, Marketing, and Customer Experience to accelerate Proteograph Product Suite adoption.
CEO Omid Farokhzad cites Bazarko's record of commercial strategy as key to next growth phase.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.